Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Administration
2 evidence topics · 3 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct informationDosing and administration
2 evidence topics · 3 sources